Also categorized in BoardNews:
Germany's Corporate Governance Problem
x hide permanently

Mylan Board Faces Challenge From Shareholder Advisory Firms

Bloomberg

A major shareholder advisory firm is calling for investors to vote to unseat all of Mylan NV ’s incumbent board directors after they failed to stop “significant destruction in shareholder value,” high executive pay and missteps during a drug pricing controversy over its allergy shot EpiPen...

Mentions: Investors Epipen Mylan